PMID- 19235261 OWN - NLM STAT- MEDLINE DCOM- 20090602 LR - 20211020 IS - 1522-2594 (Electronic) IS - 0740-3194 (Print) IS - 0740-3194 (Linking) VI - 61 IP - 3 DP - 2009 Mar TI - Evaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue. PG - 525-32 LID - 10.1002/mrm.21808 [doi] AB - The Electronic REference To access In vivo Concentrations (ERETIC) method was applied to (1)H HR-MAS spectroscopy. The accuracy, precision, and stability of ERETIC as a quantitative reference were evaluated in solution and human prostate tissue samples. For comparison, the reliability of 3-(trimethylsilyl)propionic-2,2,3,3-d(4) acid (TSP) as a quantitation reference was also evaluated. The ERETIC and TSP peak areas were found to be stable in solution over the short-term and long-term, with long-term relative standard deviations (RSDs) of 4.10% and 2.60%, respectively. Quantification of TSP in solution using the ERETIC peak as a reference and a calibrated, rotor-dependent conversion factor yielded results with a precision < or =2.9% and an accuracy error < or =4.2% when compared with the expected values. The ERETIC peak area reproducibility was superior to TSP's reproducibility, corrected for mass, in both prostate surgical and biopsy samples (4.53% vs. 21.2% and 3.34% vs. 31.8%, respectively). Furthermore, the tissue TSP peaks exhibited only 27.5% of the expected area, which would cause an overestimation of metabolite concentrations if used as a reference. The improved quantification accuracy and precision provided by ERETIC may enable the detection of smaller metabolic differences that may exist between individual tissue samples and disease states. FAU - Albers, Mark J AU - Albers MJ AD - Department of Bioengineering, University of California Berkeley, USA. FAU - Butler, Thomas N AU - Butler TN FAU - Rahwa, Iman AU - Rahwa I FAU - Bao, Nguyen AU - Bao N FAU - Keshari, Kayvan R AU - Keshari KR FAU - Swanson, Mark G AU - Swanson MG FAU - Kurhanewicz, John AU - Kurhanewicz J LA - eng GR - K01 CA096618/CA/NCI NIH HHS/United States GR - R01 CA102751/CA/NCI NIH HHS/United States GR - R01 CA102751-01A2/CA/NCI NIH HHS/United States PT - Comparative Study PT - Evaluation Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Magn Reson Med JT - Magnetic resonance in medicine JID - 8505245 RN - 0 (Protons) SB - IM MH - *Algorithms MH - Humans MH - Magnetic Resonance Spectroscopy/*methods/*standards MH - Male MH - Prostate/*metabolism MH - Protons MH - Reference Values MH - Reproducibility of Results MH - Sensitivity and Specificity MH - United States PMC - PMC2879886 MID - NIHMS192364 EDAT- 2009/02/24 09:00 MHDA- 2009/06/03 09:00 PMCR- 2010/06/02 CRDT- 2009/02/24 09:00 PHST- 2009/02/24 09:00 [entrez] PHST- 2009/02/24 09:00 [pubmed] PHST- 2009/06/03 09:00 [medline] PHST- 2010/06/02 00:00 [pmc-release] AID - 10.1002/mrm.21808 [doi] PST - ppublish SO - Magn Reson Med. 2009 Mar;61(3):525-32. doi: 10.1002/mrm.21808.